123 related articles for article (PubMed ID: 11681548)
1. Treatment resistant depression and axis I co-morbidity.
Petersen T; Gordon JA; Kant A; Fava M; Rosenbaum JF; Nierenberg AA
Psychol Med; 2001 Oct; 31(7):1223-9. PubMed ID: 11681548
[TBL] [Abstract][Full Text] [Related]
2. Treatment-resistant depression and Axis II comorbidity.
Petersen T; Hughes M; Papakostas GI; Kant A; Fava M; Rosenbaum JF; Nierenberg AA
Psychother Psychosom; 2002; 71(5):269-74. PubMed ID: 12207107
[TBL] [Abstract][Full Text] [Related]
3. Difference in remission in a Chinese population with anxious versus nonanxious treatment-resistant depression: a report of OPERATION study.
Wu Z; Chen J; Yuan C; Hong W; Peng D; Zhang C; Cao L; Fang Y
J Affect Disord; 2013 Sep; 150(3):834-9. PubMed ID: 23570952
[TBL] [Abstract][Full Text] [Related]
4. Physical co-morbidity among treatment resistant vs. treatment responsive patients with major depressive disorder.
Amital D; Fostick L; Silberman A; Calati R; Spindelegger C; Serretti A; Juven-Wetzler A; Souery D; Mendlewicz J; Montgomery S; Kasper S; Zohar J
Eur Neuropsychopharmacol; 2013 Aug; 23(8):895-901. PubMed ID: 23121858
[TBL] [Abstract][Full Text] [Related]
5. Clinical factors associated with treatment resistance in major depressive disorder: results from a European multicenter study.
Souery D; Oswald P; Massat I; Bailer U; Bollen J; Demyttenaere K; Kasper S; Lecrubier Y; Montgomery S; Serretti A; Zohar J; Mendlewicz J;
J Clin Psychiatry; 2007 Jul; 68(7):1062-70. PubMed ID: 17685743
[TBL] [Abstract][Full Text] [Related]
6. Axis III disorders in treatment-resistant major depressive disorder.
Papakostas GI; Petersen T; Iosifescu DV; Roffi PA; Alpert JE; Rosenbaum JF; Fava M; Nierenberg AA
Psychiatry Res; 2003 May; 118(2):183-8. PubMed ID: 12798983
[TBL] [Abstract][Full Text] [Related]
7. The Dutch Measure for quantification of Treatment Resistance in Depression (DM-TRD): an extension of the Maudsley Staging Method.
Peeters FP; Ruhe HG; Wichers M; Abidi L; Kaub K; van der Lande HJ; Spijker J; Huibers MJ; Schene AH
J Affect Disord; 2016 Nov; 205():365-371. PubMed ID: 27568174
[TBL] [Abstract][Full Text] [Related]
8. The lack of association between components of metabolic syndrome and treatment resistance in depression.
Sagud M; Mihaljevic-Peles A; Uzun S; Cusa BV; Kozumplik O; Kudlek-Mikulic S; Mustapic M; Barisic I; Muck-Seler D; Pivac N
Psychopharmacology (Berl); 2013 Nov; 230(1):15-21. PubMed ID: 23579429
[TBL] [Abstract][Full Text] [Related]
9. Finding factors that predict treatment-resistant depression: Results of a cohort study.
Cepeda MS; Reps J; Ryan P
Depress Anxiety; 2018 Jul; 35(7):668-673. PubMed ID: 29786922
[TBL] [Abstract][Full Text] [Related]
10. The economic impact of depression: resistance or severity?
Fostick L; Silberman A; Beckman M; Spivak B; Amital D
Eur Neuropsychopharmacol; 2010 Oct; 20(10):671-5. PubMed ID: 20624674
[TBL] [Abstract][Full Text] [Related]
11. Antidepressant resistance in adolescents with major depressive disorder: A nationwide longitudinal study.
Chen LC; Chen YH; Bai YM; Chen TJ; Chen MH; Su TP
J Affect Disord; 2020 Feb; 262():293-297. PubMed ID: 31733920
[TBL] [Abstract][Full Text] [Related]
12. Economic implications of treatment-resistant depression among employees.
Greenberg P; Corey-Lisle PK; Birnbaum H; Marynchenko M; Claxton A
Pharmacoeconomics; 2004; 22(6):363-73. PubMed ID: 15099122
[TBL] [Abstract][Full Text] [Related]
13. [Prevalence of psychiatric disorders in French general practice using the patient health questionnaire: comparison with GP case-recognition and psychotropic medication prescription].
Norton J; de Roquefeuil G; David M; Boulenger JP; Ritchie K; Mann A
Encephale; 2009 Dec; 35(6):560-9. PubMed ID: 20004287
[TBL] [Abstract][Full Text] [Related]
14. A prospective latent analysis study of Axis I psychiatric co-morbidity of DSM-IV major depressive disorder.
Melartin T; Mantere O; Ketokivi M; Isometsä E
Psychol Med; 2014 Apr; 44(5):949-59. PubMed ID: 23834913
[TBL] [Abstract][Full Text] [Related]
15. Clinical factors predicting treatment resistant depression: affirmative results from the European multicenter study.
Kautzky A; Dold M; Bartova L; Spies M; Kranz GS; Souery D; Montgomery S; Mendlewicz J; Zohar J; Fabbri C; Serretti A; Lanzenberger R; Dikeos D; Rujescu D; Kasper S
Acta Psychiatr Scand; 2019 Jan; 139(1):78-88. PubMed ID: 30291625
[TBL] [Abstract][Full Text] [Related]
16. Novel Augmentation Strategies in Major Depression.
Martiny K
Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
[TBL] [Abstract][Full Text] [Related]
17. Treatment resistant depression in women with peripartum depression.
Cepeda MS; Kern DM; Nicholson S
BMC Pregnancy Childbirth; 2019 Sep; 19(1):323. PubMed ID: 31477032
[TBL] [Abstract][Full Text] [Related]
18. Epidemiology of antidepressant medication use in the Canadian diabetes population.
Ivanova A; Nitka D; Schmitz N
Soc Psychiatry Psychiatr Epidemiol; 2010 Sep; 45(9):911-9. PubMed ID: 19730761
[TBL] [Abstract][Full Text] [Related]
19. Frequency-specific alterations in functional connectivity in treatment-resistant and -sensitive major depressive disorder.
He Z; Cui Q; Zheng J; Duan X; Pang Y; Gao Q; Han S; Long Z; Wang Y; Li J; Wang X; Zhao J; Chen H
J Psychiatr Res; 2016 Nov; 82():30-9. PubMed ID: 27459030
[TBL] [Abstract][Full Text] [Related]
20. Investigation of early and lifetime clinical features and comorbidities for the risk of developing treatment-resistant depression in a 13-year nationwide cohort study.
Huang SS; Chen HH; Wang J; Chen WJ; Chen HC; Kuo PH
BMC Psychiatry; 2020 Nov; 20(1):541. PubMed ID: 33203427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
